News
Global Oil-Demand Growth Expected to Weaken
The International Energy Agency projects a slowdown in global oil-demand growth, primarily driven by decreased travel demand in China. Despite this, China is still expected to drive most of the global demand growth.
Read more
Bakkavor Group Expects Revenue Growth in 2024
Bakkavor Group projects revenue growth for 2024 after reporting a 3.0% rise in revenue in 2023. The company remains optimistic about its future prospects despite challenges in the U.K. market.
Read more
The Future of AI Business
Discover the positive outlook for artificial intelligence (AI) in business and its influence on technology stocks. Learn about the controversy surrounding Apple's App Store payment policies.
Read more
Myomo Reports Strong Q4 Results, Expects Continued Growth
Myomo, a medical-device maker, reports strong Q4 results and expects continued growth with its MyoPro product. They aim for annual revenue of at least $100 million within five years.
Read more
U.K. Stocks Close Lower as FTSE 100 Sees Decline
The U.K. stock market ended lower, with the FTSE 100 Index falling, while some companies saw declines and others saw increases in their share prices.
Read more
Fisker Faces Uphill Battle in the Electric Vehicle Market
Fisker is encountering challenges in meeting production targets and facing an NHTSA investigation. Can they overcome these obstacles in the electric vehicle market?
Read more
JetBlue Airways Dodges a Bullet with Failed Merger
JetBlue Airways avoids a costly merger with Spirit Airlines, securing a favorable outcome for the low-cost carrier. The court ruling has significant implications for both JetBlue and Spirit, as well as the broader airline industry.
Read more
Apple Faces Possible Removal of Blood-Oxygen Sensor in Apple Watches
Apple faces potential removal of blood-oxygen sensor in watches due to legal battle with Masimo. A court ruling may force Apple to redesign two watch models.
Read more
Assessing Charles Schwab's Q4 Earnings: Challenges, Expectations, and Future Outlook
This article examines Charles Schwab's Q4 earnings report, expectations, challenges faced, and the outlook for the company. It explores the impact of cash sorting, customer reactions to higher interest rates, and possible solutions to overcome market challenges. It also discusses the recent rise in Schwab's stock and its potential for further growth. Investors eagerly await the results to assess Schwab's ability to recover and regain momentum in the financial market.
Read more
Positive Interim Data for ABBV-RGX-314 Gene Therapy in Wet AMD
Regenxbio shares positive interim results for ABBV-RGX-314 gene therapy in wet age-related macular degeneration (AMD). The therapy has shown a favorable safety profile, mild adverse events, and positive effects on visual acuity and retinal thickness.
Read more